posted by user: MAJ || 1727 views || tracked by 2 users: [display]

Epigenomics 2013 : Cell Symposia: Cancer Epigenomics


When Oct 6, 2013 - Oct 8, 2013
Where Spain
Submission Deadline Jun 21, 2013
Categories    cancer   epigenomics   epigenentics

Call For Papers

Large-scale cancer genomics and genome-wide studies of the chromatin and DNA methylation landscape are reshaping our understanding of tumor heterogeneity, evolution, and genome stability. It is clear that epigenetic regulators are critical mediators of cancer progression and drug resistance, and new classes of targeted therapeutics against epigenetic regulators are already in clinical trials.

Our goal in organizing this meeting is to gather together experts on cancer, genomics, chromatin, systems biology, and chemical biology to discuss the rapidly advancing field of cancer epigenomics and its imminent impact on new cancer therapies. We aim to provide a forum for discussion and potential future collaboration amongst clinicians, drug development companies, and those at the forefront of basic biological discovery. The ultimate goal is to advance this exciting aspect of cancer biology and inform the epigenetic cancer therapies of tomorrow.

Related Resources

DATA 2020   AI and Big Data in Cancer: From Innovation to Impact
NZBCS 2020   The Second New Zealand Breast Cancer Symposium in 2020
Biological Assemblies 2020   Cell Symposia: Biological Assemblies: Phase Transitions and More
Metabolites 2020   Cell Symposia: Metabolites in Signaling and Disease
ABB 2020   The 3rd International Conference on Applied Biochemistry and Biotechnology
Cell Symposia 2020   Infection Biology in the Age of the Microbiome
Cell Symposia 2020   Gene- and Cell-Based Therapies: CRISPR, Stem Cells, and Beyond
New Horizons in B Cell Biology 2020   Cell Press Presents New Horizons in B Cell Biology